Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beat Flühmann

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Regulatory Toxicology and Pharmacology : RTP|September 7, 2012
Nanoparticle iron medicinal products - Requirements for approval of intended copies of non-biological complex drugs (NBCD) and the importance of clinical comparative studiesGerrit Borchard, Beat Flühmann, Stefan Mühlebach
Forum of Nutrition|August 19, 2006
Development of bioactive substances for functional foods--scientific and other aspectsPeter Weber, Beat Flühmann, Manfred Eggersdorfer
European Journal of Hospital Pharmacy : Science and Practice|March 31, 2018
Medication practice in hospitals: are nanosimilars evaluated and substituted correctly?Josefien Knoeff, Beat Flühmann, Stefan Mühlebach
International Journal of Molecular Sciences|February 26, 2022
Criticality of Surface Characteristics of Intravenous Iron-Carbohydrate Nanoparticle Complexes: Implications for Pharmacokinetics and PharmacodynamicsFelix Funk, Beat Flühmann, Amy E Barton
International Journal of Molecular Sciences|September 23, 2022
Correction: Funk et al. Criticality of Surface Characteristics of Intravenous Iron-Carbohydrate Nanoparticle Complexes: Implications for Pharmacokinetics and Pharmacodynamics. <i>Int. J. Mol. Sci.</i> 2022, <i>23</i>, 2140Felix Funk, Beat Flühmann, Amy E Barton
The AAPS Journal|September 27, 2018
Correction to: Reflections on FDA Draft Guidance for Products Containing Nanomaterials: Is the Abbreviated New Drug Application (ANDA) a Suitable Pathway for Nanomedicines?Emily Marden, Ioanna Ntai, Scott Bass, et al.
American Journal of Pharmaceutical Education|October 7, 2021
The Growing Field of Nanomedicine and Its Relevance to Pharmacy CurriculaVolkmar Weissig, Tamer Elbayoumi, Beat Flühmann, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 23, 2018
Nanomedicines: The magic bullets reaching their target?Beat Flühmann, Ioanna Ntai, Gerrit Borchard, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 4, 2023
Putting square pegs in round holes: Why traditional pharmacokinetic principles cannot universally be applied to iron-carbohydrate complexesAmy Barton Alston, Reinaldo Digigow, Beat Flühmann, et al.
Brain Research|November 7, 2002
Paracrine/autocrine function of adrenomedullin in peripheral nerves of ratsCharles E Dumont, Roman Muff, Beat Flühmann, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Regulatory Toxicology and Pharmacology : RTP|September 7, 2012
Nanoparticle iron medicinal products - Requirements for approval of intended copies of non-biological complex drugs (NBCD) and the importance of clinical comparative studiesGerrit Borchard, Beat Flühmann, Stefan Mühlebach
Forum of Nutrition|August 19, 2006
Development of bioactive substances for functional foods--scientific and other aspectsPeter Weber, Beat Flühmann, Manfred Eggersdorfer
European Journal of Hospital Pharmacy : Science and Practice|March 31, 2018
Medication practice in hospitals: are nanosimilars evaluated and substituted correctly?Josefien Knoeff, Beat Flühmann, Stefan Mühlebach
International Journal of Molecular Sciences|February 26, 2022
Criticality of Surface Characteristics of Intravenous Iron-Carbohydrate Nanoparticle Complexes: Implications for Pharmacokinetics and PharmacodynamicsFelix Funk, Beat Flühmann, Amy E Barton
International Journal of Molecular Sciences|September 23, 2022
Correction: Funk et al. Criticality of Surface Characteristics of Intravenous Iron-Carbohydrate Nanoparticle Complexes: Implications for Pharmacokinetics and Pharmacodynamics. <i>Int. J. Mol. Sci.</i> 2022, <i>23</i>, 2140Felix Funk, Beat Flühmann, Amy E Barton
The AAPS Journal|September 27, 2018
Correction to: Reflections on FDA Draft Guidance for Products Containing Nanomaterials: Is the Abbreviated New Drug Application (ANDA) a Suitable Pathway for Nanomedicines?Emily Marden, Ioanna Ntai, Scott Bass, et al.
American Journal of Pharmaceutical Education|October 7, 2021
The Growing Field of Nanomedicine and Its Relevance to Pharmacy CurriculaVolkmar Weissig, Tamer Elbayoumi, Beat Flühmann, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 23, 2018
Nanomedicines: The magic bullets reaching their target?Beat Flühmann, Ioanna Ntai, Gerrit Borchard, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 4, 2023
Putting square pegs in round holes: Why traditional pharmacokinetic principles cannot universally be applied to iron-carbohydrate complexesAmy Barton Alston, Reinaldo Digigow, Beat Flühmann, et al.
Brain Research|November 7, 2002
Paracrine/autocrine function of adrenomedullin in peripheral nerves of ratsCharles E Dumont, Roman Muff, Beat Flühmann, et al.
Pageof 4